Literature DB >> 10926314

Major depression and impaired glucose tolerance.

B Weber1, U Schweiger, M Deuschle, I Heuser.   

Abstract

Hypercortisolism is a frequent endocrine sign in major depression and cortisol is a well-known anti-insulinergic hormone. Impaired oral glucose tolerance has already been described in major depression. However, thus far no information is available on spontaneous, circadian insulin secretion in patients. We studied 26 depressed inpatients along with 33 age- and sex-matched controls. Blood samples were collected at 30-minute intervals over a period of 26 hours (h) for estimation of cortisol, insulin and glucose. No differences in 24 h mean-insulin and glucose concentrations were detectable despite significantly reduced caloric consumption in patients. At the second morning a strictly standardized test meal of 2125 kjoule was given. Insulin and glucose responses to the test meal were significantly increased in hypercortisolemic patients compared to controls. Hence, patients with major depression have an impaired insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926314     DOI: 10.1055/s-2000-7742

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  20 in total

Review 1.  Depression in type 2 diabetes mellitus: prevalence, impact, and treatment.

Authors:  Katherine Semenkovich; Miriam E Brown; Dragan M Svrakic; Patrick J Lustman
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

Review 2.  Diabetes among refugee populations: what newly arriving refugees can learn from resettled Cambodians.

Authors:  Julie Wagner; S Megan Berthold; Thomas Buckley; Sengly Kong; Theanvy Kuoch; Mary Scully
Journal:  Curr Diab Rep       Date:  2015-08       Impact factor: 4.810

3.  Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression.

Authors:  Nina C Donner; Christian D Montoya; Jodi L Lukkes; Christopher A Lowry
Journal:  Psychoneuroendocrinology       Date:  2011-09-15       Impact factor: 4.905

4.  A randomized, controlled trial of a stress management intervention for Latinos with type 2 diabetes delivered by community health workers: Outcomes for psychological wellbeing, glycemic control, and cortisol.

Authors:  Julie Ann Wagner; Angela Bermudez-Millan; Grace Damio; Sofia Segura-Perez; Jyoti Chhabra; Cunegundo Vergara; Richard Feinn; Rafael Perez-Escamilla
Journal:  Diabetes Res Clin Pract       Date:  2016-08-04       Impact factor: 5.602

Review 5.  [Depression and diabetes mellitus type 2].

Authors:  M Deuschle; U Schweiger
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

6.  Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.

Authors:  Enrico Domenici; David R Willé; Federica Tozzi; Inga Prokopenko; Sam Miller; Astrid McKeown; Claire Brittain; Dan Rujescu; Ina Giegling; Christoph W Turck; Florian Holsboer; Edward T Bullmore; Lefkos Middleton; Emilio Merlo-Pich; Robert C Alexander; Pierandrea Muglia
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

7.  The role of health behaviors in mediating the relationship between depressive symptoms and glycemic control in type 2 diabetes: a structural equation modeling approach.

Authors:  Ching-Ju Chiu; Linda A Wray; Elizabeth A Beverly; Oralia G Dominic
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-03       Impact factor: 4.328

8.  HPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings.

Authors:  William Coryell; Jess Fiedorowicz; Mark Zimmerman; Elizabeth Young
Journal:  Psychoneuroendocrinology       Date:  2008-04-02       Impact factor: 4.905

9.  Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes.

Authors:  Julie Wagner; Nancy A Allen; Leah M Swalley; Gail D Melkus; Robin Whittemore
Journal:  Diabetes Res Clin Pract       Date:  2009-08-31       Impact factor: 5.602

10.  The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review.

Authors:  Kim E Innes; Heather K Vincent
Journal:  Evid Based Complement Alternat Med       Date:  2007-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.